Advertisement
Advertisement

MNOV

MNOV logo

Medicinova, Inc.

1.74
USD
Sponsored
-0.01
-0.86%
Jan 30, 15:57 UTC -5
Closed
exchange

After-Market

1.74

0.00
0.00%

MNOV Earnings Reports

Positive Surprise Ratio

MNOV beat 28 of 38 last estimates.

74%

Next Report

Date of Next Report
Feb 13, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.12
Implied change from Q3 25 (Revenue/ EPS)
--
/
+100.00%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+100.00%

Medicinova, Inc. earnings per share and revenue

On Nov 12, 2025, MNOV reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 41.18% surprise. Revenue reached 123.32 thousand, compared to an expected --, with a --% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.12 USD, with revenue projected to reach -- USD, implying an increase of 100.00% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Medicinova, Inc. reported EPS of -$0.06, beating estimates by 41.18%, and revenue of $123.32K, -- -- expectations.
The stock price moved down -1.91%, changed from $1.57 before the earnings release to $1.54 the day after.
The next earning report is scheduled for Feb 13, 2026.
Based on 4 analysts, Medicinova, Inc. is expected to report EPS of -$0.12 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement